Sunwin International Increases Availability Of Two Veterinary Medicines To Combat Swine Flu Virus In China

Main Category: Swine Flu
Also Included In: Flu / Cold / SARS;  Veterinary
Article Date: 04 Jun 2009 - 1:00 PDT

email to a friend   printer friendly   view / write opinions   rate article

Sunwin International Neutraceuticals, Inc. (OTCBB: SUWN), a leader in the production and distribution of Chinese herbs, veterinary medicines and one of the world's leading producers of all natural, zero calorie Stevia in China, announced today that the company has increased the availability of two veterinary medicines, Huangqiduotang vaccine and Jinfang Detoxification Powder to treat swine flu that has recently spread in North America and other parts of the world. These products, currently used for controlling various types of influenza in China, have demonstrated effectiveness in controlling swine flu outbreaks among livestock.

Both veterinary medicines have been developed by authoritative veterinary experts within China. Jinfang Detoxification Powder is mixed in animal feeds, and Huangqiduotang vaccine is delivered via injection. Both products are antiviral, increasing the immunity of livestock to various types of flu viruses including swine flu. Sunwin is increasing its inventory of these products for distribution in China and potentially to other countries in the Far East if the virus spreads to these areas.

Laiwang Zhang, Chairman of Sunwin International, commented, "We believe that a quick response is essential to treating viruses like swine flu which can quickly cause pandemic concerns as it has in North America. Making these treatments more available in China ahead of potential threats is key to preventing widespread losses in livestock that could disrupt food supply chains at a substantial cost to the industry and the consumer. We are confident that broad availability of these products in China will help to control this type of virus threat and ease the minds of consumers troubled by this recent outbreak abroad."

Source
Sunwin International Neutraceuticals, Inc.